These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 7559865

  • 1. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [Abstract] [Full Text] [Related]

  • 2. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S, Di Rella F, Pivonello R, Di Somma C, Klain M, Maurelli L, Scarpa R, Colao A, Merola B, Lombardi G.
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [Abstract] [Full Text] [Related]

  • 4. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D.
    Osteoporos Int; 2001 Oct; 12(2):117-23. PubMed ID: 11303711
    [Abstract] [Full Text] [Related]

  • 5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 7. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB, Hietanen P, Tiitinen A, Ylikorkala O.
    J Clin Endocrinol Metab; 1998 Apr 15; 83(4):1158-62. PubMed ID: 9543133
    [Abstract] [Full Text] [Related]

  • 8. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE, Bone HG, Caulfield MP, Kagan R, Buinewicz A, Chen E, Rosenberg E, Reitz RE.
    Bone; 2007 May 15; 40(5):1222-30. PubMed ID: 17331821
    [Abstract] [Full Text] [Related]

  • 9. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K, Kristoffersson AO, Lorentzon RP.
    Surgery; 1997 Nov 15; 122(5):882-7. PubMed ID: 9369887
    [Abstract] [Full Text] [Related]

  • 10. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep 15; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct 15; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

  • 16. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 15; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

  • 17. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul 15; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study.
    Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J.
    Eur J Endocrinol; 2006 Jan 15; 154(1):109-18. PubMed ID: 16381999
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.